BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$413.26+1.97 (+0.48%)
Close on Nov 17, 2026Market cap $46.99BP/E 73.9Yield –
BeOne Medicines price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BeOne Medicines's price to book ratio was 9.2× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 2.4× to 9.9×, with a median of 6.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.2× | +1.0 |
| 2025 | Dec 31, 2025 | 8.1× | +2.4 |
| 2024 | Dec 31, 2024 | 5.7× | +0.7 |
| 2023 | Dec 29, 2023 | 5.0× | +0.1 |
| 2022 | Dec 30, 2022 | 4.9× | −2.6 |
| 2021 | Dec 31, 2021 | 7.5× | +2.0 |
| 2020 | Dec 31, 2020 | 5.5× | +4.7 |
| 2019 | Dec 31, 2019 | 0.8× | −3.4 |
| 2018 | Dec 31, 2018 | 4.2× | −1.7 |
| 2017 | Dec 29, 2017 | 5.9× | +0.6 |
| 2016 | Dec 30, 2016 | 5.3× | – |
See a number that looks wrong?